Shijiazhuang Yiling Pharmaceutical | Sustainability Performance
Develops, manufactures, and distributes pharmaceutical products. Activities include R&D, production, and marketing of medicines, focusing on therapeutic treatments and compliance with quality standards.
1992
China
10,001+ employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#9164
Overallⓘ#581
in Chinaⓘ#224
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Energy consumptionWater ManagementAir & land impactNature and biodiversitySocial
Diversity and InclusionPay GapsExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Aligned
Critical
Controversy level
- Shijiazhuang Yiling Pharmaceutical Co Ltd, Chinese TCM (Traditional Chinese Medicine) major (Lianhua Qingwen capsules), has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate disclosure of TCM product quality including the contested 20202023 'Lianhua Qingwen' COVID19 marketing claims under Chinese SAMR investigation, plus periodic class actions over alleged inadequate disclosure affecting Chinese institutional shareholders.
